4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-24-011195
President and CEO sold 19,642 shares at $4.86 ($95,460)
- President and CEO acquired 180,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mattessich Antony C. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-03 | Grant or award : show line 1 in the form | +180,400 | 608,343 | D | ||
| 2024-02-05 | Sale : show line 2 in the form | +19,642 | $4.86 | $95,460 | 588,701 | D |
| Open-market sales · 19,642 sh · avg $4.86 · $95,460 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-03 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +549,400 | 549,400 | D |
Loading xslF345X05/tm245295-1_4seq1.xml…